Invention Grant
- Patent Title: Purified forms of rofecoxib, methods of manufacture and use
-
Application No.: US17852252Application Date: 2022-06-28
-
Publication No.: US11559509B2Publication Date: 2023-01-24
- Inventor: Raymond D. Skwierczynski , Bradford C. Sippy , Jean-Marie Schneider , Simon H. Drouin , Charles Guerin
- Applicant: Tremeau Pharmaceuticals, Inc.
- Applicant Address: US MA Concord
- Assignee: Tremeau Pharmaceuticals, Inc.
- Current Assignee: Tremeau Pharmaceuticals, Inc.
- Current Assignee Address: US MA Concord
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K31/341
- IPC: A61K31/341
Abstract:
The subject matter disclosed herein relates to rofecoxib, also known as TRM-201 or RXB-201, its method of manufacture, and use. In certain aspects, the highly pure or substantially pure rofecoxib as provided herein has a favorable purity profile and is the active ingredient in a pharmaceutical composition that is administered to treat or prevent a number of conditions, including pain associated with a condition caused by a bleeding disorder.
Public/Granted literature
- US20220362206A1 PURIFIED FORMS OF ROFECOXIB, METHODS OF MANUFACTURE AND USE Public/Granted day:2022-11-17
Information query
